Press Releases

Usona Statement on Phase 3 Study of Psilocybin for Major Depressive Disorder (MDD) (uAspire)

March 20, 2024

Usona Institute Research Unveils New Compounds with Observed Psychedelic-like Activity

January 10, 2024

Usona statement on JAMA publication of PSIL201 data

August 31, 2023

Usona Identifies Controlled Crystal Engineering Process for Large-Scale Synthesis of Psilocybin Polymorphs

February 7, 2022

Crystallographic Discoveries Bring New Clarity to Pharmaceutical Psilocybin Polymorph Characterization

December 20, 2021

Usona Institute Breaks Ground for Global Center in Psychedelic Science

August 3, 2021

Usona Institute Publishes Synthesis and Characterization of cGMP 5-MeO-DMT

December 8, 2020

Usona Institute Publishes Breakthrough Development in Scalable Psilocybin Synthesis

August 3, 2020